[
    {
        "title": "ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes - Yahoo Finance",
        "description": "ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes  Yahoo Finance",
        "published date": "Mon, 09 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9yZXNtZWQtcm1kLWdhaW5zLXN0cm9uZy1kZXZpY2UtMTUxNTAwMzYyLmh0bWzSAVRodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9yZXNtZWQtcm1kLWdhaW5zLXN0cm9uZy1kZXZpY2UtMTUxNTAwMzYyLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio - Nasdaq",
        "description": "3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio  Nasdaq",
        "published date": "Mon, 09 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvMy1yZWFzb25zLXRvLXJldGFpbi1pbm9nZW4taW5nbi1zdG9jay1pbi15b3VyLXBvcnRmb2xpby0x0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Here's Why You Should Retain Teleflex (TFX) Stock for Now - Nasdaq",
        "description": "Here's Why You Should Retain Teleflex (TFX) Stock for Now  Nasdaq",
        "published date": "Mon, 09 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvaGVyZXMtd2h5LXlvdS1zaG91bGQtcmV0YWluLXRlbGVmbGV4LXRmeC1zdG9jay1mb3Itbm93LTLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "enVVeno (NVNO) Plans to Expedite enVVe Development for CVI - Zacks Investment Research",
        "description": "enVVeno (NVNO) Plans to Expedite enVVe Development for CVI  Zacks Investment Research",
        "published date": "Mon, 09 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIxNjI3NDMvZW52dmVuby1udm5vLXBsYW5zLXRvLWV4cGVkaXRlLWVudnZlLWRldmVsb3BtZW50LWZvci1jdmnSAWVodHRwczovL3d3dy56YWNrcy5jb20vYW1wL3N0b2NrL25ld3MvMjE2Mjc0My9lbnZ2ZW5vLW52bm8tcGxhbnMtdG8tZXhwZWRpdGUtZW52dmUtZGV2ZWxvcG1lbnQtZm9yLWN2aQ?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity - Zacks Investment Research",
        "description": "Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity  Zacks Investment Research",
        "published date": "Mon, 09 Oct 2023 13:57:25 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIxNjI3MTIvdmVyYWRpZ20tbWRyeC1mZGItdmVsYS10by1lbmhhbmNlLXBoYXJtYWN5LWNvbm5lY3Rpdml0edIBZGh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8yMTYyNzEyL3ZlcmFkaWdtLW1kcngtZmRiLXZlbGEtdG8tZW5oYW5jZS1waGFybWFjeS1jb25uZWN0aXZpdHk?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]